248 related articles for article (PubMed ID: 28838173)
1. Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015.
Billah MM; Zaman K; Estivariz CF; Snider CJ; Anand A; Hampton LM; Bari TIA; Russell KL; Chai SJ
J Infect Dis; 2017 Jul; 216(suppl_1):S114-S121. PubMed ID: 28838173
[TBL] [Abstract][Full Text] [Related]
2. Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Bangladesh.
Estivariz CF; Snider CJ; Anand A; Hampton LM; Bari TI; Billah MM; Chai SJ; Wassilak SG; Heffelfinger JD; Zaman K
J Infect Dis; 2017 Jul; 216(suppl_1):S122-S129. PubMed ID: 28838154
[TBL] [Abstract][Full Text] [Related]
3. Temperature integrity and exposure to freezing temperature during vaccine transfer under the universal immunization program in Three States of India.
Das MK; Arora NK; Mathew T; Vyas B; Sindhu M; Yadav A
Indian J Public Health; 2019; 63(2):139-142. PubMed ID: 31219063
[TBL] [Abstract][Full Text] [Related]
4. Cold chain status at immunisation centres in Ethiopia.
Berhane Y; Demissie M
East Afr Med J; 2000 Sep; 77(9):476-9. PubMed ID: 12862137
[TBL] [Abstract][Full Text] [Related]
5. A comparative assessment of cold chain management using the outbreak of circulating vaccine-derived polio virus type 2 as a surrogate marker in Oyo State, Nigeria-2019.
Babatunde OA; Olatunji MB; Omotajo OR; Ikwunne OI; Hamzat Z; Sola ST
Pan Afr Med J; 2020; 37():313. PubMed ID: 33654532
[TBL] [Abstract][Full Text] [Related]
6. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
[TBL] [Abstract][Full Text] [Related]
7. Use of cool water packs to prevent freezing during vaccine transportation at the country level.
Kartoglu U; Ganivet S; Guichard S; Aiyer V; Bollen P; Maire D; Altay B
PDA J Pharm Sci Technol; 2009; 63(1):11-26. PubMed ID: 19455939
[TBL] [Abstract][Full Text] [Related]
8. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
Gamage D; Ginige S; Palihawadana P
WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
[TBL] [Abstract][Full Text] [Related]
9. Challenges of cold chain quality for routine EPI in south-west Burkina-Faso: An assessment using automated temperature recording devices.
Sow C; Sanou C; Medah C; Schlumberger M; Mireux F; Ouédraogo I; Ouédraogo SM; Betsem E
Vaccine; 2018 Jun; 36(26):3747-3755. PubMed ID: 29779921
[TBL] [Abstract][Full Text] [Related]
10. Vaccines in the national immunization programme.
Bass AG
P N G Med J; 1993 Jun; 36(2):141-57. PubMed ID: 8154196
[TBL] [Abstract][Full Text] [Related]
11. Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations.
Qi W; Orgel S; Francon A; Randolph TW; Carpenter JF
J Pharm Sci; 2018 Aug; 107(8):2070-2078. PubMed ID: 29709487
[TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
13. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
14. Status of cold-chain maintenance in Chandigarh.
Goel NK; Pathak R; Galhotra A; Dankal C; Swami HM
Indian J Public Health; 2008; 52(1):37-9. PubMed ID: 18700720
[TBL] [Abstract][Full Text] [Related]
15. Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon.
Ateudjieu J; Kenfack B; Nkontchou BW; Demanou M
BMC Res Notes; 2013 Mar; 6():101. PubMed ID: 23497720
[TBL] [Abstract][Full Text] [Related]
16. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
17. Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains.
Cai W; Ping L; Shen W; Liu J; Zhang M; Zhou J; Peng J; Wang M; Zhu Y; Ji G; Wang X; Ji Q; Lai C; Shi L; Che Y; Sun M
Hum Vaccin Immunother; 2020 Aug; 16(8):1866-1874. PubMed ID: 32118517
[TBL] [Abstract][Full Text] [Related]
18. Vaccine storage and cold chain monitoring in the North West region of Cameroon: a cross sectional study.
Yakum MN; Ateudjieu J; Walter EA; Watcho P
BMC Res Notes; 2015 Apr; 8():145. PubMed ID: 25884186
[TBL] [Abstract][Full Text] [Related]
19. Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013-2016.
Wkly Epidemiol Rec; 2015 Jul; 90(27):337-43. PubMed ID: 26151981
[No Abstract] [Full Text] [Related]
20. The origins of the vaccine cold chain and a glimpse of the future.
Lloyd J; Cheyne J
Vaccine; 2017 Apr; 35(17):2115-2120. PubMed ID: 28364918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
